Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis
2 clinical trials · Condition
◉ Watch Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis
| Record | Firm | Date |
|---|---|---|
| A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS) (NCT06681623) | Neurology Center of New England P.C. | 2024-08-13 |
| Long-term Follow-up of Fingolimod Phase II Study Patients (NCT02307838) | Novartis Pharmaceuticals | 2014-06-01 |
Track Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis automatically
Every clearance here is in the API, with alerts when new ones post.